Thursday, December 17, 2009

Orchid Chemicals has sold of its generic injectable Pharma business for US$400mn to fund its debt repayments and pursue new growth opportunities. (ET)

JOIN US!!

JOIN US!!
Send SMS for "STUDY" on 09825677777

web search ...